Stem Cell Research Foundation Funds Project
ROCKVILLE, Md. - John D. Gearhart, Ph.D. at the Johns Hopkins School of mediine and his co-investigator Michael J. Shamblott, Ph.D. will work with human pluripotent stem cells after receiving a grant from the Stem Cell Research Foundation.
Gearhart, one of the two researchers who first reported isolating human stem cells in November 1998, will work on making stem cells hardier for research.
The cells, which may provide an answer to replacing diseased cells in Alzheimer's, Parkinson's, juvenile diabetes, heart disease and cancer patients, have the potential to develop into any type of human cell.
The $300,000 grant will help Gearhart's team develop cell lines from human tissue sources.
For more information, log on to: www.stemcellresearchfoundation.org
IDEA in Action: A Strategic Approach to Contamination Control
January 14th 2025Adopting IDEA—identify, define, explain, apply—streamlines contamination control. Infection control professionals can mitigate risks through prevention, intervention, and training, ensuring safer health care environments and reducing frequent contamination challenges.
Balancing Freedom and Safety: When Public Health Mandates Are Necessary
January 9th 2025Public health mandates, such as lockdowns, masking, and vaccination, balance liberty and safety, ensuring critical protections during pandemics like COVID-19 while fostering long-term survival through science.
Long-Term Chronicles: Infection Surveillance Guidance in Long-Term Care Facilities
January 8th 2025Antibiotic stewardship in long-term care facilities relies on McGeer and Loeb criteria to guide infection surveillance and appropriate prescribing, ensuring better outcomes for residents and reducing resistance.
Considering Avian Flu: World Health Organization Expert Warns Against Raw Milk
January 6th 2025Drinking raw milk poses risks of disease transmission, especially with H5N1 outbreaks. Expert Richard J. Webby, PhD, advises against raw cow or goat milk consumption due to its unpredictable and significant risks.
